Eam Investors, LLC Rocket Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $1.29 Million - $1.54 Million	-32,625 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$43.34 - $65.91 $129,153 - $196,411	2,980 Added 10.05%	32,625 $1.45 Million
Q4 2020 Feb 11, 2021	BUY	$23.3 - $59.57 $690,728 - $1.77 Million	29,645 New	29,645 $1.63 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.